Back
Monte Rosa Therapeutics Vs. Dave Industry Stock Comparison
Buy
84
GLUE
Monte Rosa Therapeutics
Last Price:
10.38
Seasonality Move:
19.52%
Buy
99
DAVE
Dave
Last Price:
99.01
Seasonality Move:
73.86%
Buy
84
Monte Rosa Therapeutics (GLUE)
is a Buy
Is Monte Rosa Therapeutics a Buy, Sell or Hold?
- The current Monte Rosa Therapeutics [GLUE] share price is $10.36. The Score for GLUE is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- GLUE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
99
Dave (DAVE)
is a Buy
Is Dave a Buy, Sell or Hold?
- The current Dave [DAVE] share price is $98.68. The Score for DAVE is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- DAVE is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
GLUE Stock Price Chart
What is Monte Rosa Therapeutics's stock price today?
-
The Monte Rosa Therapeutics share price today is $10.36
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLUE is experiencing buying pressure, which is a positive indicator for future bullish movement.
DAVE Stock Price Chart
GLUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 69.98 | Buy |
| Chaikin Money Flow: | 770811 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.72 - 9.74) | Buy |
| Bollinger Bands (100): | (4.29 - 7.83) | Buy |
DAVE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.57 | Buy |
| Relative Strength Index (14 RSI): | 79.73 | Buy |
| Chaikin Money Flow: | 61535 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.26 - 85.52) | Buy |
| Bollinger Bands (100): | (28.73 - 60.47) | Buy |
GLUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.76 | Buy |
| 20-day SMA: | 8.84 | Buy |
| 50-day SMA: | 7.02 | Buy |
| 200-day SMA: | 5.74 | Buy |
| 8-day EMA: | 8.99 | Buy |
| 20-day EMA: | 8.51 | Buy |
| 50-day EMA: | 7.48 | Buy |
| 200-day EMA: | 6.03 | Buy |
DAVE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 86.38 | Buy |
| 20-day SMA: | 70.08 | Buy |
| 50-day SMA: | 53.04 | Buy |
| 200-day SMA: | 40.89 | Buy |
| 8-day EMA: | 87 | Buy |
| 20-day EMA: | 74.22 | Buy |
| 50-day EMA: | 58.81 | Buy |
| 200-day EMA: | 40.81 | Buy |
Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and a decrease next year of $0.60 per share.
Dave Earnings Growth & DAVE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.66 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.39 per share.
Monte Rosa Therapeutics Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dave Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||